Loading the section…
The price of Heron Therapeutics, Inc. (HRTX) on October 9, 2026 is 0.4100 USD, +13.89% on the day. Over 52 weeks the stock traded between 0.2600 USD and 1.58 USD; the price now sits 11% of the way up that range. Over the past year the price changed by -69.63%. Market capitalization is 77.21 million USD, rank 230 among 372 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −68.46 %
Heron Therapeutics, Inc. trades on Nasdaq under the ticker HRTX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks HRTX has traded between 0.2600 $ and 1.58 $. As of 9 October 2026 the price stood 11.36 % of the way from the 52-week low to the high.
Over one year HRTX shares fell 69.63 %; over six months they fell 51.76 %. Volatility over 90 days is 101.39 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.5, below the sector median of 4.0. Price to book is 8.5, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 0.3500 | 0.4100 | 0.3500 | 0.4100 | 3M |
| 8 October 2026 | 0.3700 | 0.3800 | 0.3500 | 0.3600 | 2M |
| 7 October 2026 | 0.3300 | 0.3900 | 0.3300 | 0.3800 | 4M |
| 6 October 2026 | 0.3700 | 0.3800 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121, US
Heron Therapeutics, Inc. reported revenue of 151M $ and a net loss of 31M $ over the last four quarters. Net margin is −20.53 %. Revenue changed by +1.48 % year over year. Earnings per share are −0.17 $. Market capitalisation is 77M $.
HRTX has a return on equity of −338.63 %, below the sector median of −41.68 %. Return on assets is −12.57 %, above the sector median of −32.11 %. Operating margin is −6.94 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 0.3200 |
| 0.3300 |
| 2M |
| 5 October 2026 | 0.3600 | 0.3800 | 0.3500 | 0.3700 | 3M |
| 2 October 2026 | 0.3600 | 0.4100 | 0.3400 | 0.3500 | 4M |
| 1 October 2026 | 0.3200 | 0.3600 | 0.3100 | 0.3600 | 3M |
| 30 September 2026 | 0.3100 | 0.3400 | 0.3000 | 0.3100 | 2M |
| 29 September 2026 | 0.2900 | 0.3200 | 0.2900 | 0.3100 | 3M |
| 28 September 2026 | 0.2900 | 0.3000 | 0.2800 | 0.2900 | 1M |
| 25 September 2026 | 0.2900 | 0.3000 | 0.2800 | 0.2900 | 2M |
| 24 September 2026 | 0.3000 | 0.3000 | 0.2800 | 0.2900 | 929,800 |
| 23 September 2026 | 0.3000 | 0.3000 | 0.2800 | 0.2900 | 2M |
| 22 September 2026 | 0.2800 | 0.3100 | 0.2700 | 0.3000 | 4M |
| 21 September 2026 | 0.3100 | 0.3100 | 0.2600 | 0.2700 | 9M |
| 18 September 2026 | 0.3200 | 0.3200 | 0.3100 | 0.3100 | 4M |
| 17 September 2026 | 0.3300 | 0.3300 | 0.3100 | 0.3200 | 914,200 |
| 16 September 2026 | 0.3200 | 0.3200 | 0.3100 | 0.3200 | 1M |
| 15 September 2026 | 0.3100 | 0.3200 | 0.3100 | 0.3100 | 1M |
| 14 September 2026 | 0.3200 | 0.3200 | 0.3100 | 0.3200 | 1M |